Sort by
Refine Your Search
-
(SMIs) better manage their symptoms/interference and facilitate medium-to-long term recovery. The project is led by Queen Mary University of London and the post holder will be employed by UoP. This is an
-
solver who wants to be part of a dynamic team. Learn more about the innovative work led by Dr. Don Ingber here: https://wyss.harvard.edu/technology/erapid-multiplexed-electrochemical-sensors-for-fast
-
team. Learn more about the innovative work led by Dr. Don Ingber here: https://wyss.harvard.edu/technology/erapid-multiplexed-electrochemical-sensors-for-fast-accurate-portable-diagnostics/. What you’ll
-
at the intersection of academia and practice. For more information on D^3, please visit https://d3.harvard.edu/labs . D^3 is looking for candidates with diverse backgrounds and/or new perspectives. There are no
-
electromagnetic interference; ii) Design of printing patterns for conductive (electromagnetic) inks; iii) Printing of substrates with varying printing parameters; iv) Electromagnetic shielding test; v) and
-
Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more